Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 as adjunct to ECT in manic episode of bipolar disorder
IRCT20160523028008N26Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of omega-3 fatty acid in bipolar disorder (BD), sponsored by Hamadan University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
omega-3 fatty acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20160523028008N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N26.